MENLO PARK, CA, Jan. 6, 2023 – Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, genetic blood disorders and autoimmune diseases, today announced that Ivan Dimov, Ph.D., Orca Bio’s co-founder and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference.
The company presentation will take place on Monday, January 9, 2023, at 7:30 AM PST at the Westin St. Francis in the Mission Bay Room on the 32nd floor.